Skip to content
OpenCapital
Get started

Omega Healthcare Investors OHI Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

VTR
VentasVTR
$57.04M+0.8%
Realty Income logo
Realty IncomeO
$2.09B+890%
Welltower logo
WelltowerWELL
——
American Healthcare REIT logo
American Healthcare REITAHR
——
Tenet Healthcare logo
Tenet HealthcareTHC
——
W.P. Carey Inc. logo
W.P. Carey Inc.WPC
——

Other financials

Income statement

See full
Revenue$323.0M+16.7%
Net income$151.0M+38.5%
EPS (diluted)$0.47+42.4%

Balance sheet

See full
Cash & equivalents$26.1M-92.9%
Total debt$29.5M-2.7%
Total equity$5.2B+9.5%
Total assets$10.2B+5.4%

Cash flow

See full
Operating cash flow$215.5M+18.4%
CapEx$8.8M-56.6%
Free cash flow$206.7M+27.8%

Valuation

See full
Market cap$13.26B+20.7%
P/E21×-3.6×
P/S10.7×+0.6×

Profitability

See full
Operating margin43.5%—
Net margin51.1%+9.8pp
FCF margin68.2%+1.0pp

Returns & leverage

See full
Return on equity12.7%+1.9pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Omega Healthcare Investors in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Omega Healthcare Investors’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omega Healthcare Investors's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omega Healthcare Investors's noncontrolling interests in subsidiaries?
Omega Healthcare Investors (OHI) reported noncontrolling interests in subsidiaries of $263.54M in Q1 2026.
How has Omega Healthcare Investors's noncontrolling interests in subsidiaries changed year-over-year?
Omega Healthcare Investors's noncontrolling interests in subsidiaries increased by 37.9% year-over-year, from $191.09M to $263.54M.
What is the long-term trend for Omega Healthcare Investors's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Omega Healthcare Investors's noncontrolling interests in subsidiaries has grown at a 5.9% compound annual growth rate (CAGR), from $194.73M to $259.2M.